Weiss Multi-Strategy Advisers’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-38,259
Closed -$1.46M 605
2023
Q3
$1.46M Buy
+38,259
New +$1.57M 0.03% 410
2023
Q2
Sell
-40,839
Closed -$1.56M 694
2023
Q1
$1.56M Buy
+40,839
New +$1.92M 0.04% 457
2016
Q1
Sell
-10,000
Closed -$173K 499
2015
Q4
$173K Hold
10,000
0.01% 353
2015
Q3
$134K Buy
+10,000
New +$201K 0.01% 375
2014
Q2
Sell
-17,500
Closed -$222K 808
2014
Q1
$222K Buy
17,500
+5,020
+40% +$74.5K ﹤0.01% 890
2013
Q4
$187K Buy
+12,480
New +$161K ﹤0.01% 912

Other funds holding HALO

Weiss Multi-Strategy Advisers's HALO Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Halozyme (HALO) in Q4 2023, closing a stake of 38,259 shares — an estimated $1.46M sold.

Weiss Multi-Strategy Advisers first reported a position in HALO in Q4 2013 and held it in 6 quarters. The position peaked at $1.56M in Q1 2023. 410 funds tracked by Wall St. Rank hold HALO as of Q4 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Halozyme position as of Q4 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 38,259 Halozyme shares in Q4 2023, an estimated $1.46M.
  • Weiss Multi-Strategy Advisers first reported a position in Halozyme in Q4 2013 and held it in 6 quarters.
  • Weiss Multi-Strategy Advisers's Halozyme position peaked at $1.56M in Q1 2023.
  • 410 funds tracked by Wall St. Rank held Halozyme as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.